Cyclodextrin glycosyltransferase (CGTase) polypeptides with modified hydrolysis activity
View Patent ↗An enzyme is described which enzyme is derived from family 13 of α-amylases. The enzyme variant is obtainable by modifying a CGTase or a maltogenic α-amylase. The enzyme is useful in preparing a food or a food product such as bakery products.
1. An isolated and/or purified cyclodextrin glycosyltransferase (CGTase) polypeptide with increased hydrolase activity, comprising the amino acid sequence as set forth in SEQ ID NO: 1 or 3, wherein
(a) said CGTase polypeptide has a variation at position 230, A230V, and
(b) said CGTase polypeptide optionally has amino acid substitutions selected from the group consisting of F21L, A245T, A357T, N94S, R47W, R47L, R47Q, K232L, E264A, Y633A, W616A, W662A, L600A, A231V, F260E, and F260I.
2. The CGTase polypeptide according to claim 1 wherein said CGTase polypeptide on incubation with starch has a lower endo-amylase activity than the reference enzyme under the same conditions.
3. The CGTase polypeptide according to claim 1 or 2 , wherein said CGTase polypeptide is prepared from DNA that has been mutated such that the resultant transcription product is or comprises said CGTase polypeptide.
4. A method of using an enzyme variant according to claim 1 in preparing a food product, wherein the food product is optionally a bakery product, and wherein the method optionally comprises one or more of the following steps:
(i) admixing the enzyme variant with at least one additional food ingredient or foodstuff ingredient,
(ii) packaging said food product,
(iii) labeling said packaged food product as a food product.
5. A process of treating starch comprising contacting the starch with a variant enzyme and allowing the enzyme to generate from the starch one or more linear products, and wherein the enzyme variant is an enzyme variant according to claim 1 .